AURX

NUO THERAPEUTICS INC NEW—+0.00 (—)

Prev Close—·MCap$77.3M·P/E—·Vol—·Yield—

▲

Buys (12M)

$9.5K

▼

Sells (12M)

$397.5K

◆

Net Activity

Net Seller

$388.0K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at NUO THERAPEUTICS INC NEW (AURX) has been dominated by selling, with 1 insider purchase totaling $9.5K and 4 insider sales totaling $397.5K. The most recent insider transaction was by JORDEN DAVID EMERSON (director, officer: CEO/CFO), who purchased $9.5K worth of shares on Aug 31, 2026. NUO THERAPEUTICS INC NEW operates in the Technology sector, within the General industry, with a market cap of $77.3M.

AURX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 31, 2026	JORDEN DAVID EMERSON	director, officer: CEO/CFO	Buy	8,773	$1.09	$9.5K	2,070,000
Jan 1, 2026	JORDEN DAVID EMERSON	CEO/CFO	Sell	25,381	$1.97	$50.0K	0
Dec 17, 2025	WINZER C ERIC	Director	Sell	13,750	$2.00	$27.5K	0
Dec 9, 2025	Mintz Paul	Director	Sell	9,091	$2.20	$20.0K	0
Nov 28, 2025	JORDEN DAVID EMERSON	CEO/CFO	Sell	200,000	$1.50	$300.0K	0
Aug 1, 2025	JORDEN DAVID EMERSON	CEO/CFO	Sell	21,313	$1.74	$37.1K	0
Aug 1, 2025	Mintz Paul	Director	Sell	20,115	$1.74	$35.0K	0
Aug 1, 2025	WINZER C ERIC	Director	Sell	27,659	$1.74	$48.1K	0
Jul 30, 2025	SHEEDY CHARLES E	10% Owner	Buy	133,333	$1.50	$200.0K	0
Sep 19, 2024	SHEEDY CHARLES E	10% Owner	Buy	125,000	$0.75	$93.8K	0
May 20, 2024	SHEEDY CHARLES E	10% Owner	Buy	100,000	$0.75	$75.0K	0
Dec 19, 2023	SHEEDY CHARLES E	10% Owner	Buy	150,000	$0.50	$75.0K	0
Aug 1, 2023	SHEEDY CHARLES E	10% Owner	Buy	62,500	$2.00	$125.0K	0
Nov 9, 2022	JORDEN DAVID EMERSON	CEO/CFO	Sell	112,500	$1.50	$168.8K	0
Apr 29, 2022	SHEEDY CHARLES E	10% Owner	Buy	804,868	$1.00	$804.9K	0

AURX Insider Buying Activity

The following table shows recent insider purchases of NUO THERAPEUTICS INC NEW (AURX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 31, 2026	JORDEN DAVID EMERSON	director, officer: CEO/CFO	Buy	8,773	$1.09	$9.5K	2,070,000
Jul 30, 2025	SHEEDY CHARLES E	10% Owner	Buy	133,333	$1.50	$200.0K	0
Sep 19, 2024	SHEEDY CHARLES E	10% Owner	Buy	125,000	$0.75	$93.8K	0
May 20, 2024	SHEEDY CHARLES E	10% Owner	Buy	100,000	$0.75	$75.0K	0
Dec 19, 2023	SHEEDY CHARLES E	10% Owner	Buy	150,000	$0.50	$75.0K	0
Aug 1, 2023	SHEEDY CHARLES E	10% Owner	Buy	62,500	$2.00	$125.0K	0
Apr 29, 2022	SHEEDY CHARLES E	10% Owner	Buy	804,868	$1.00	$804.9K	0

AURX Insider Selling Activity

The following table shows recent insider sales of NUO THERAPEUTICS INC NEW (AURX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Jan 1, 2026	JORDEN DAVID EMERSON	CEO/CFO	Sell	25,381	$1.97	$50.0K
Dec 17, 2025	WINZER C ERIC	Director	Sell	13,750	$2.00	$27.5K
Dec 9, 2025	Mintz Paul	Director	Sell	9,091	$2.20	$20.0K
Nov 28, 2025	JORDEN DAVID EMERSON	CEO/CFO	Sell	200,000	$1.50	$300.0K
Aug 1, 2025	JORDEN DAVID EMERSON	CEO/CFO	Sell	21,313	$1.74	$37.1K
Aug 1, 2025	Mintz Paul	Director	Sell	20,115	$1.74	$35.0K
Aug 1, 2025	WINZER C ERIC	Director	Sell	27,659	$1.74	$48.1K
Nov 9, 2022	JORDEN DAVID EMERSON	CEO/CFO	Sell	112,500	$1.50	$168.8K

AURX Insiders

JORDEN DAVID EMERSON

director, officer: CEO/CFO

Bought $9.5KSold $555.8K

5 tradesLast: Aug 31, 2026

WINZER C ERIC

Director

Sold $75.6K

2 tradesLast: Dec 17, 2025

Mintz Paul

Director

Sold $55.0K

2 tradesLast: Dec 9, 2025

SHEEDY CHARLES E

10% Owner

Bought $1.37M

6 tradesLast: Jul 30, 2025

Similar Stocks to AURX

AGNCZ

AGNC Investment Corp. 8.75% Series H Fixed-Rate Cumulative Redeemable Preferred Stock

$25.64+0.10%

$28.00B

AGNCP

AGNC Investment Corp. Depositary Shares Each Representing a 1/1,000th Interest in a Share of 6.125% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

$25.44+0.00%

$9.83B

KYN

Kayne Anderson Energy Infrastructure Fund, Inc.

$14.96+0.91%

$2.33B

RVT

Royce Small-Cap Trust, Inc.

$18.52-0.40%

$2.20B

BCAT

BlackRock Capital Allocation Term Trust